McGregor, F;
Dick, AD;
Burke, T;
(2021)
Achieving Quiescence with Fluocinolone Implants.
Case Reports in Ophthalmology
, 12
pp. 356-362.
10.1159/000513221.
Preview |
Text
Fraia Case report 2021.pdf - Published Version Download (956kB) | Preview |
Abstract
Persistent anterior uveitis causing cystoid macular oedema may necessitate either intraocular or systemic immunosuppression. This case report highlights how a newly licenced treatment, fluocinolone acetonide (Iluvien, Alimera Sciences Ltd., England, UK) achieves quiescence in refractory and steroid-dependent disease and in the presence of an acute relapse.
Type: | Article |
---|---|
Title: | Achieving Quiescence with Fluocinolone Implants |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1159/000513221 |
Publisher version: | https://doi.org/10.1159/000513221 |
Language: | English |
Additional information: | This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission. |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Institute of Ophthalmology |
URI: | https://discovery.ucl.ac.uk/id/eprint/10130397 |
Archive Staff Only
View Item |